A Phase 1, Two-part, Open-label, Drug-drug Interaction Study in Healthy Male Adult Participants to Evaluate the Effects of BMS-986371 on the Pharmacokinetics of Methotrexate in the Presence and Absence of Sulfasalazine
Latest Information Update: 14 Feb 2023
At a glance
- Drugs Folinic acid (Primary) ; Gamcemetinib (Primary) ; Methotrexate (Primary) ; Sulfasalazine (Primary)
- Indications Ankylosing spondylitis
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 06 Feb 2023 Status changed from recruiting to completed.
- 10 Oct 2022 Status changed from not yet recruiting to recruiting.
- 08 Jul 2022 New trial record